GL1X · GenesisL1 explorer

MolNFT v1 · #91403 · protein

Structure of the C-terminal domain of the type III effector XCV3220 (xopl)

4FC9 · Uncharacterized protein: “Structure of the C-terminal domain of the type III effector XCV3220 (xopl)”. X-ray diffraction, 1 ligand (CL), 5 pockets (best druggability 0.64). MolNFT v1 #91403 on GenesisL1: 3D structure, binding sites…

PDB
4FC9
Type
protein
Length
515 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized protein
UniProt
Q3BQL2
Ligands
CL
Pockets
5 · best druggability 0.64

Structure

x-ray diffraction · 3 distinct chains · 49% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BUncharacterized proteinprotein17549% helix, 4% strandQ3BQL2
AUncharacterized proteinprotein17150% helix, 4% strandQ3BQL2
CUncharacterized proteinprotein16949% helix, 4% strandQ3BQL2

Ligands and binding sites

  • CL · Chloride ion · ion · 3 copies · chains B, A, C
  • EDO · 1,2-ethanediol · additive · 3 copies · chains B, A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14990.640.7655EDO
21370.450.7723empty
31370.450.7626empty
41450.430.7523empty
5580.260.7215empty

Interfaces

3 interfaces between chains.

  • B–C · 551 Ų buried · 12 hydrogen bonds · protein-protein
  • B–A · 249 Ų buried · 3 hydrogen bonds · protein-protein
  • A–C · 142 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (engineered).

Compared structures

  • 4FC9 · Structure of the C-terminal domain of the type III effector Xcv3220 (XopL) · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.